CN108902596A - 一种鸡内金金钱草制品及其制备方法 - Google Patents
一种鸡内金金钱草制品及其制备方法 Download PDFInfo
- Publication number
- CN108902596A CN108902596A CN201810638904.5A CN201810638904A CN108902596A CN 108902596 A CN108902596 A CN 108902596A CN 201810638904 A CN201810638904 A CN 201810638904A CN 108902596 A CN108902596 A CN 108902596A
- Authority
- CN
- China
- Prior art keywords
- parts
- endothelium corneum
- gigeriae galli
- corneum gigeriae
- money
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000003038 endothelium Anatomy 0.000 title claims abstract description 62
- 238000002360 preparation method Methods 0.000 title claims abstract description 30
- 239000002994 raw material Substances 0.000 claims abstract description 41
- 241000233866 Fungi Species 0.000 claims abstract description 37
- 235000015888 Aralia elata Nutrition 0.000 claims abstract description 35
- 241001632409 Aralia elata Species 0.000 claims abstract description 35
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 34
- 235000008397 ginger Nutrition 0.000 claims abstract description 34
- 235000009496 Juglans regia Nutrition 0.000 claims abstract description 32
- 235000020234 walnut Nutrition 0.000 claims abstract description 32
- 241000219991 Lythraceae Species 0.000 claims abstract description 31
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 31
- 240000008042 Zea mays Species 0.000 claims abstract description 31
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 31
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 31
- 235000005822 corn Nutrition 0.000 claims abstract description 31
- 240000008067 Cucumis sativus Species 0.000 claims abstract description 30
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 claims abstract description 30
- 239000000463 material Substances 0.000 claims abstract description 26
- 239000008159 sesame oil Substances 0.000 claims abstract description 23
- 235000011803 sesame oil Nutrition 0.000 claims abstract description 23
- 241000234314 Zingiber Species 0.000 claims description 31
- 241000245665 Taraxacum Species 0.000 claims description 30
- 239000000843 powder Substances 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 11
- 238000000227 grinding Methods 0.000 claims description 10
- 238000010348 incorporation Methods 0.000 claims description 9
- 238000001514 detection method Methods 0.000 claims description 5
- 230000036961 partial effect Effects 0.000 claims description 5
- 238000003860 storage Methods 0.000 claims description 5
- 235000015001 Cucumis melo var inodorus Nutrition 0.000 claims description 3
- 240000002495 Cucumis melo var. inodorus Species 0.000 claims description 3
- 244000269722 Thea sinensis Species 0.000 claims description 3
- 235000013361 beverage Nutrition 0.000 claims description 3
- 239000002552 dosage form Substances 0.000 claims description 3
- 235000012907 honey Nutrition 0.000 claims description 3
- 239000002674 ointment Substances 0.000 claims description 3
- 229940100688 oral solution Drugs 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- -1 pulvis Substances 0.000 claims description 3
- 235000013616 tea Nutrition 0.000 claims description 3
- 238000003556 assay Methods 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 238000012545 processing Methods 0.000 claims description 2
- 238000007873 sieving Methods 0.000 claims description 2
- 241000758789 Juglans Species 0.000 claims 6
- 241000345998 Calamus manan Species 0.000 claims 2
- 235000012950 rattan cane Nutrition 0.000 claims 2
- 240000007049 Juglans regia Species 0.000 abstract description 26
- 239000003814 drug Substances 0.000 abstract description 23
- 230000000694 effects Effects 0.000 abstract description 16
- 208000001130 gallstones Diseases 0.000 abstract description 13
- 230000001225 therapeutic effect Effects 0.000 abstract description 5
- 241000721047 Danaus plexippus Species 0.000 abstract description 4
- 206010043417 Therapeutic response unexpected Diseases 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 244000273928 Zingiber officinale Species 0.000 abstract description 3
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 210000000232 gallbladder Anatomy 0.000 description 14
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- 238000000034 method Methods 0.000 description 9
- 210000000941 bile Anatomy 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 241000287828 Gallus gallus Species 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 235000012000 cholesterol Nutrition 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 239000004575 stone Substances 0.000 description 5
- 241000246500 Gentianella aspera Species 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 201000001883 cholelithiasis Diseases 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 238000007689 inspection Methods 0.000 description 4
- 238000011068 loading method Methods 0.000 description 4
- 238000012856 packing Methods 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 244000025254 Cannabis sativa Species 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 208000004845 Cholecystolithiasis Diseases 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 3
- 210000003445 biliary tract Anatomy 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 239000012267 brine Substances 0.000 description 3
- 239000008845 cholagoga Substances 0.000 description 3
- 229940124571 cholagogue Drugs 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
- 239000010931 gold Substances 0.000 description 3
- 229910052737 gold Inorganic materials 0.000 description 3
- 208000006454 hepatitis Diseases 0.000 description 3
- 231100000283 hepatitis Toxicity 0.000 description 3
- 230000002443 hepatoprotective effect Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 230000003908 liver function Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 238000012946 outsourcing Methods 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 3
- 229910001220 stainless steel Inorganic materials 0.000 description 3
- 239000010935 stainless steel Substances 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 238000002604 ultrasonography Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 2
- 244000144730 Amygdalus persica Species 0.000 description 2
- 235000003097 Artemisia absinthium Nutrition 0.000 description 2
- 240000001851 Artemisia dracunculus Species 0.000 description 2
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 2
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 2
- 235000005979 Citrus limon Nutrition 0.000 description 2
- 244000131522 Citrus pyriformis Species 0.000 description 2
- 208000022072 Gallbladder Neoplasms Diseases 0.000 description 2
- 208000012895 Gastric disease Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 208000000913 Kidney Calculi Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010028813 Nausea Diseases 0.000 description 2
- 206010029148 Nephrolithiasis Diseases 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 239000001138 artemisia absinthium Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000000013 bile duct Anatomy 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229940099352 cholate Drugs 0.000 description 2
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 201000010175 gallbladder cancer Diseases 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000008693 nausea Effects 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 238000004062 sedimentation Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010006002 Bone pain Diseases 0.000 description 1
- 229910001369 Brass Inorganic materials 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000208365 Celastraceae Species 0.000 description 1
- 206010008617 Cholecystitis chronic Diseases 0.000 description 1
- 206010008635 Cholestasis Diseases 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 240000007126 Citrus medica var. sarcodactylis Species 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000218176 Corydalis Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000219112 Cucumis Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 235000013717 Houttuynia Nutrition 0.000 description 1
- 240000000691 Houttuynia cordata Species 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241001183967 Isodon Species 0.000 description 1
- 241000758791 Juglandaceae Species 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 208000008771 Lymphadenopathy Diseases 0.000 description 1
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241001499733 Plantago asiatica Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000008350 Pruritus Vulvae Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 235000000336 Solanum dulcamara Nutrition 0.000 description 1
- 206010042135 Stomatitis necrotising Diseases 0.000 description 1
- 238000008050 Total Bilirubin Reagent Methods 0.000 description 1
- 241000224527 Trichomonas vaginalis Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000006568 Urinary Bladder Calculi Diseases 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 206010056530 Vulvovaginal pruritus Diseases 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 201000009361 ascariasis Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000010951 brass Substances 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 230000005189 cardiac health Effects 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- 208000003167 cholangitis Diseases 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 231100000359 cholestasis Toxicity 0.000 description 1
- 230000007870 cholestasis Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 210000001096 cystic duct Anatomy 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 208000022532 enlargement of lymph nodes Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 229940002508 ginger extract Drugs 0.000 description 1
- 235000020708 ginger extract Nutrition 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 244000000053 intestinal parasite Species 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N linoleic acid group Chemical group C(CCCCCCC\C=C/C\C=C/CCCCC)(=O)O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 201000008585 noma Diseases 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000037351 starvation Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 230000010304 tumor cell viability Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000006438 vascular health Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/34—Tea substitutes, e.g. matè; Extracts or infusions thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
- A61K36/515—Gentiana
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/52—Juglandaceae (Walnut family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
本发明公开了一种鸡内金金钱草制品及其制备方法,鸡内金1‑3份、生姜3‑5份、核桃仁4‑8份、大金钱草2‑4份、黑木耳3‑6份、玉米须1.5‑3份、蒲公英1‑3份、柴胡1.5‑4份、龙胆草1‑2份、纯香油1‑4份,黄瓜藤2‑4份,龙牙楤木1‑3份。本发明原料为纯天然原料,安全可靠,无毒副作用,所选药材配伍相宜,符合中医药学和现代医药学理论,根据君臣佐使的配伍原则,达到意想不到的治疗效果,采用常规原料,便于取材,价格低廉,制备方法简单。本申请制备的鸡内金金钱草制品,按照疗程服用后,对于胆结石有明显的治疗效果。
Description
技术领域
本发明属于保健食品领域,尤其涉及一种鸡内金金钱草制品及其制备方法。
背景技术
胆结石又称胆石症,是指胆道系统包括胆囊或胆管内发生结石的疾病;胆道感染是属于常见的疾病。按发病部位分为胆囊结石和胆管结石。结石在胆囊内形成后,可刺激胆囊黏膜,不仅可引起胆囊的慢性炎症,而且当结石嵌顿在胆囊颈部或胆囊管后,还可以引起继发感染,导致胆囊的急性炎症。由于结石对胆囊黏膜的慢性刺激,还可能导致胆囊癌的发生,有报告此种胆囊癌的发生率可达1%~ 2%。
引起胆结石的原因主要包括:1、胆汁成分发生变化:是胆结石形成的最常见原因。胆汁主要由胆盐、胆固醇、无机盐等组成,如胆固醇浓度过高,可导致胆汁沉淀,结石形成;2、胆汁淤积;3、感染:如胆道蛔虫症;4、胆道运动功能障碍:如不吃早餐、糖尿病人等。
现有技术治疗胆结石的方法是摘除胆囊或微创取石,使患者不仅要承受手术的痛苦,同时与正常人相比少了一个胆,对日后的生活存在很大的影响。
专利申请号为201210560147.7的发明专利提供了公开了一种排胆结石的药物,主方由以下组分组成:橄榄油、柠檬汁;附方由以下药材组成:柴胡、丹参、元胡、香附、川棟子、当归、白芍、积壳、郁金、佛手、北芪、菊花、龙胆草、溪黄草、茵陈、车前草、金钱草、鱼腥草、泽泻、鸡内金、滑石、甘草。该发明与现有技术相比,采用橄榄油和柠檬汁混合后做成的主方,患者空腹将主方服用后,经过一夜将结石经肠道排出体外,但是该专利原料种类繁多,制备比较复杂。
发明内容
为了克服以上现有技术中存在的问题,提供一种鸡内金金钱草制品,采用纯天然原料,安全可靠,无毒副作用,所选药材配伍相宜,符合中医药学和现代医药学理论,根据君臣佐使的配伍原则,对于胆结石症状达到意想不到的治疗效果,采用常规原料,便于取材,价格低廉,同时制备方法简单。
一种鸡内金金钱草制品,包含以下重量份的原料组份:鸡内金1-3份、生姜3-5份、核桃仁4-8份、大金钱草2-4份、黑木耳3-6份、玉米须1.5-3份、蒲公英1-3份、柴胡1.5-4份、龙胆草1-2份、纯香油1-4份,黄瓜藤2-4份,龙牙楤木1-3份。
优选的是,包含以下重量份的原料组份:鸡内金1份、生姜3份、核桃仁4 份、大金钱草2份、黑木耳3份、玉米须1.5份、蒲公英1份、柴胡1.5份、龙胆草1份、纯香油1份、黄瓜藤2份、龙牙楤木1份。
上述任一方案中优选的是,包含以下重量份的原料组份:鸡内金1.5份、生姜4份、核桃仁6份、大金钱草3份、黑木耳4.5份、玉米须2份、蒲公英2份、柴胡3份、龙胆草1.5份、纯香油2.5份,黄瓜藤3份、龙牙楤木2份。
上述任一方案中优选的是,包含以下重量份的原料组份:鸡内金3份、生姜 5份、核桃仁8份、大金钱草4份、黑木耳6份、玉米须3份、蒲公英3份、柴胡4份、龙胆草2份、纯香油4份,黄瓜藤4份、龙牙楤木3份。
上述任一方案中优选的是,所述鸡内金金钱草制品的剂型为散剂、粉剂、片剂、颗粒剂、汤剂、口服液、蜜膏体、蜜露、饮料或茶包制剂中的任意一种。
上述任一方案中优选的是,所述中药组合物的剂型为散剂、粉剂、片剂、颗粒剂、汤剂、口服液、蜜膏体、蜜露、饮料或茶包制剂中的任意一种。
本发明还提供上述鸡内金金钱草制品的制备方法,鸡内金金钱草制品为片剂,制备方法包括以下步骤:
(1).将鸡内金、生姜、核桃仁、大金钱草、黑木耳、玉米须、蒲公英、柴胡、龙胆草、黄瓜藤、龙牙楤木原料处理后按配比在粉碎车间粉碎后,称量;
(2).把步骤(1)中称量好的原料和纯香油在混合机中进行混合,设定混合时间、转速,混合好后放出原料;
(3).将混合好的原料采用压片机进行压片;
(4).压片后进行包装,包装完成后,产品化验室检测合格入库。
优选的是,所述步骤(1)过筛前需要对鸡内金、生姜、核桃仁、大金钱草、黑木耳、玉米须、蒲公英、柴胡、龙胆草、黄瓜藤、龙牙楤木进行检验,检验合格后按配比在粉碎车间超微粉碎。
上述任一方案中优选的是,所述步骤(1)粉碎为超微粉碎,超微粉碎后超微粉粒径为10~60μm。
上述任一方案中优选的是,采用气流粉碎机进行超微粉碎,气流粉碎机的气流压力为600~8000kPa,进料速度为180~200r·min-1,分级频率为20~30Hz,粉碎时间为20~30min,得超微粉。
上述任一方案中优选的是,步骤(2)中的混合时间为20-30分钟,20转/ 分。
上述任一方案中优选的是,所述步骤(3)中压片机压力3.8千牛,填充量 5mm,每片净含量在1.05-1.10克之间。
上述任一方案中优选的是,所述步骤(4)包装的具体做法为:每瓶装60 片中药组合物片剂,之后封口,封口完将瓶体传递到外包装车间进行贴标,装箱。
本申请配方中采用鸡内金、生姜、核桃仁、大金钱草、黑木耳、玉米须、蒲公英、柴胡、龙胆草、黄瓜藤、龙牙楤木、纯香油作为原料。
纯香油,降压,含有不饱和脂肪酸,是有益心脏和血管健康,极易被人体分解吸收和利用,促进胆固醇的代谢,预防胆汁沉淀,清除动脉血管壁上的沉积物,从而起到软化血管、防治动肪硬化的作用,润肠通便。
龙胆草,清热燥湿,泻肝胆火。用于:湿热黄疸,阴肿阴痒,带下,强中,湿疹瘙痒,目赤,耳聋,胁痛,口苦,惊风抽搐。李时珍在《本草纲目》中说: "相火寄在肝里,有泻无补,故龙胆气益肝胆之气,正以其能泻肝胆之邪热也。
柴胡,镇静,抗病毒,解热抗炎,保肝利胆。柴胡中还含有大量的黄铜,这种物质能够有效的促进胆汁的排出量,并且胆盐的含量也可以大大增加。
蒲公英,公英的功效:清热解毒,可用于热毒证,尤善清肝热,治疗肝热目赤肿痛,以及多种感染、化脓性疾病。消痈散结,治疗热毒壅结于肌肉所致的痈肿疮毒,高热不退。
黑木耳,黑木耳具有益气强身、滋肾养胃、活血等功能,它能抗血凝、抗血栓、降血脂,黑木耳的作用降低血粘,软化血管,使血液流动动畅,减少心血管病发生。黑木耳还有较强的吸附作用,经常食用利于使体内产生的垃圾及时排出体外。黑木耳对胆结石、肾结石也有较好的化解功能,黑木耳的作用因为它所含的植物碱具有促进消化道、泌尿道各种腺体分泌的特性,植物碱能协同这些分泌物催化结石,润滑肠道。
大金钱草,清热,利湿,消肿,解毒。治黄疸,水肿,胆结石、肾结石、膀胱结石,反胃噎膈,跌打损伤,疔疮肿毒。。
玉米须,清热消暑,利尿消肿,米须能促进胆汁排泄,所以可作为利胆药用于没有并发症的慢性胆囊炎或胆汁排出障碍的胆管炎。和退黄的茵陈配合,还可以治疗肝炎导致的黄疸。
生姜,姜味辛性温,长于发散风寒、化痰止咳,又能温中止呕、解毒,临床上常用于治疗外感风寒及胃寒呕逆等证,前人称之为“呕家圣药”。生姜提取液具有显著抑制皮肤真菌和杀来头阴道滴虫的功效,可治疗各种痈肿疮毒。生姜有抑制癌细胞活性、降低癌的毒害作用,可以起到防癌的功效。
鸡内金的功效:消食健胃,涩精止遗。消积滞,健脾胃。治食积胀满,呕吐反胃,泻痢,疳积,消渴,遗溺,喉痹乳蛾,牙疳口疮。味甘性平,入脾胃膀胱经,具有健胃消食,化积排石,固摄缩尿等作用。现代药理研究认为,鸡内金主要含有胃激素,角蛋白,氨基酸等成分。有增加胃液分泌量和胃肠消化能力,加快胃的排空速率等作用。是一种很常用的中药。
核桃仁,为胡桃科植物的果实。核桃仁含有丰富的营养素,每百克含蛋白质 15~20克,脂肪60~70克,碳水化合物10克;并含有人体必需的钙、磷、铁等多种微量元素和矿物质,以及胡萝卜素、核黄素等多种维生素。核桃中所含脂肪的主要成分是亚油酸甘油脂,食后不但不会使胆固醇升高,还能减少肠道对胆固醇的吸收。
龙牙楤木,入药以后味甘略苦,性质平和,能祛风除湿也能利尿消肿还能活血止痛,平时它能治疗人类的肝炎与淋巴结肿大以及肾炎水肿还有白带异常等常见病,另外它对人类的关节疼痛以及风湿骨痛也有不错的治疗作用。能防癌抗癌,龙牙楤木中含有多种天然的化合物,这些物质可以直接消灭人体内的癌症细胞也能抑制细胞癌变,可以提高人体免疫力,平时经常食用龙牙楤木可以起到明显的防癌抗癌作用。能保肝利胆,龙牙楤木能保肝利胆,它不但能调节胆汁分泌,还能修复受损的肝细胞,也能促进肝细胞再生,消除肝脏的炎症,对人类的肝炎与肝硬化以及肝腹水都有明显治疗作用,现在市场上热销的肝病用药龙牙肝泰胶囊就是用龙牙楤木提取物加工而成的。
有益效果
本发明提供一种鸡内金金钱草制品及其制备方法,包含以下重量份的原料组份:鸡内金1-3份、生姜3-5份、核桃仁4-8份、大金钱草2-4份、黑木耳3-6份、玉米须1.5-3份、蒲公英1-3份、柴胡1.5-4份、龙胆草1-2份、纯香油1-4份,黄瓜藤2-4份,龙牙楤木1-3份。本发明原料种类为纯天然原料,安全可靠,无毒副作用,所选药材配伍相宜,符合中医药学和现代医药学理论,根据君臣佐使的配伍原则,达到意想不到的治疗效果,采用常规原料,便于取材,价格低廉,制备方法简单。本申请制备的鸡内金金钱草制品,按照疗程服用后,对于胆结石的症状均有明显的治疗效果。
具体实施方式
为了更好理解本发明的技术方案和优点,以下通过具体实施方式,对本发明做进一步说明。
实施例1.1
一种鸡内金金钱草制品,包含以下重量份的原料组份:鸡内金1份、生姜3 份、核桃仁4份、大金钱草2份、黑木耳3份、玉米须1.5份、蒲公英1份、柴胡1.5份、龙胆草1份、纯香油1份、黄瓜藤2份、龙牙楤木1份。
上述鸡内金金钱草制品为片剂,制备方法,包括以下步骤:
步骤(1)、将鸡内金、生姜、核桃仁、大金钱草、黑木耳、玉米须、蒲公英、柴胡、龙胆草、黄瓜藤、龙牙楤木原料预处理后,在常温下进行干燥粉碎,上述产品检验合格的原料鸡内金、生姜、核桃仁、大金钱草、黑木耳、玉米须、蒲公英、柴胡、龙胆草、黄瓜藤、龙牙楤木按工艺处方配比在粉碎车间采用气流粉碎机进行超微粉碎,气流粉碎机的气流压力为600~8000kPa,进料速度为 180~200r·min-1,分级频率为20~30Hz,粉碎时间为20~30min,得超微粉,超微粉碎后超微粉粒径为10~60μm,粉碎后所有物料在称量间用电子秤进行称量;原料预处理包括将鸡内金、生姜、核桃仁、大金钱草、黑木耳、玉米须、蒲公英、柴胡、龙胆草、黄瓜藤、龙牙楤木分别在盐水中进行浸泡,盐水浓度为 5-10%,清洗,捞出后常温下晾干。
步骤(2)、把称量车间称量好的原料经过无菌传递窗传递到槽型混合车间,车间温度14度、湿度30%,把原料和纯香油投放到CH-200混合机里,混合时间为20-30分钟,20转/分,按工艺要求设定混合时间,用不锈钢桶放出物料;混合时,通入氮气,保护有效成分。
步骤(3)、将混合好原料经过无菌传递窗传递到压片车间进行压片,压片机型号ZPW-19B,压片机压力3.8千牛,填充量5mm,每片净含量1克,每10 分钟检查一次净含量,要求净含量达到1.05-1.10克之间;
步骤(4)、每瓶装60片中药组合物片剂,之后封口,封口完将瓶体传递到外包装车间进行贴标,装箱;将内包装车间传递的瓶子贴标签,标签打印生产日期,贴好瓶签装入大箱,每箱装120瓶;
步骤(5)、产品化验室检测合格入库。
实施例2
一种鸡内金金钱草制品,包含以下重量份的原料组份:鸡内金1.5份、生姜 4份、核桃仁6份、大金钱草3份、黑木耳4.5份、玉米须2份、蒲公英2份、柴胡3份、龙胆草1.5份、纯香油2.5份,黄瓜藤3份、龙牙楤木2份。
上述鸡内金金钱草制品为片剂,制备方法,包括以下步骤:
步骤(1)、将鸡内金、生姜、核桃仁、大金钱草、黑木耳、玉米须、蒲公英、柴胡、龙胆草、黄瓜藤、龙牙楤木原料预处理后,在常温下进行干燥粉碎,上述产品检验合格的原料鸡内金、生姜、核桃仁、大金钱草、黑木耳、玉米须、蒲公英、柴胡、龙胆草、黄瓜藤、龙牙楤木按工艺处方配比在粉碎车间采用气流粉碎机进行超微粉碎,气流粉碎机的气流压力为600~8000kPa,进料速度为 180~200r·min-1,分级频率为20~30Hz,粉碎时间为20~30min,得超微粉,超微粉碎后超微粉粒径为10~60μm,粉碎后所有物料在称量间用电子秤进行称量;原料预处理包括将鸡内金、生姜、核桃仁、大金钱草、黑木耳、玉米须、蒲公英、柴胡、龙胆草、黄瓜藤、龙牙楤木分别在盐水中进行浸泡,盐水浓度为 5-10%,清洗,捞出后常温下晾干。
步骤(2)、把称量车间称量好的原料经过无菌传递窗传递到槽型混合车间,车间温度14度、湿度30%,把原料和纯香油投放到CH-200混合机里,混合时间为20-30分钟,20转/分,按工艺要求设定混合时间,用不锈钢桶放出物料;混合时,通入氮气,保护有效成分。
步骤(3)、将混合好原料经过无菌传递窗传递到压片车间进行压片,压片机型号ZPW-19B,压片机压力3.8千牛,填充量5mm,每片净含量1克,每10 分钟检查一次净含量,要求净含量达到1.05-1.10克之间;
步骤(4)、每瓶装60片中药组合物片剂,之后封口,封口完将瓶体传递到外包装车间进行贴标,装箱;将内包装车间传递的瓶子贴标签,标签打印生产日期,贴好瓶签装入大箱,每箱装120瓶;
步骤(5)、产品化验室检测合格入库。
实施例3
一种鸡内金金钱草制品,包含以下重量份的原料组份:鸡内金3份、生姜5 份、核桃仁8份、大金钱草4份、黑木耳6份、玉米须3份、蒲公英3份、柴胡 4份、龙胆草2份、纯香油4份,黄瓜藤4份、龙牙楤木3份。
上述鸡内金金钱草制品为片剂,制备方法,包括以下步骤:
步骤(1)、将鸡内金、生姜、核桃仁、大金钱草、黑木耳、玉米须、蒲公英、柴胡、龙胆草、黄瓜藤、龙牙楤木原料预处理后,在常温下进行干燥粉碎,上述产品检验合格的原料鸡内金、生姜、核桃仁、大金钱草、黑木耳、玉米须、蒲公英、柴胡、龙胆草、黄瓜藤、龙牙楤木按工艺处方配比在粉碎车间采用气流粉碎机进行超微粉碎,气流粉碎机的气流压力为600~8000kPa,进料速度为 180~200r·min-1,分级频率为20~30Hz,粉碎时间为20~30min,得超微粉,超微粉碎后超微粉粒径为10~60μm,粉碎后所有物料在称量间用电子秤进行称量;原料预处理包括将鸡内金、生姜、核桃仁、大金钱草、黑木耳、玉米须、蒲公英、柴胡、龙胆草、黄瓜藤、龙牙楤木分别在盐水中进行浸泡,盐水浓度为 5-10%,清洗,捞出后常温下晾干。
步骤(2)、把称量车间称量好的原料经过无菌传递窗传递到槽型混合车间,车间温度14度、湿度30%,把原料和纯香油投放到CH-200混合机里,混合时间为20-30分钟,20转/分,按工艺要求设定混合时间,用不锈钢桶放出物料;混合时,通入氮气,保护有效成分。
步骤(3)、将混合好原料经过无菌传递窗传递到压片车间进行压片,压片机型号ZPW-19B,压片机压力3.8千牛,填充量5mm,每片净含量1克,每10 分钟检查一次净含量,要求净含量达到1.05-1.10克之间;
步骤(4)、每瓶装60片中药组合物片剂,之后封口,封口完将瓶体传递到外包装车间进行贴标,装箱;将内包装车间传递的瓶子贴标签,标签打印生产日期,贴好瓶签装入大箱,每箱装120瓶;
步骤(5)、产品化验室检测合格入库。
对比例1
一种鸡内金金钱草制品,制备方法和实施例2相同,不同的是包含以下重量份的原料组份:生姜4份、核桃仁6份、大金钱草3份、黑木耳4.5份、玉米须2 份、蒲公英2份、柴胡3份、龙胆草1.5份、纯香油2.5份,黄瓜藤3份、龙牙楤木2份。
对比例2
一种鸡内金金钱草制品,制备方法和实施例2相同,不同的是,鸡内金1.5 份、生姜4份、核桃仁6份、大金钱草3份、黑木耳4.5份、玉米须2份、蒲公英2份、柴胡3份、龙胆草1.5份、纯香油2.5份,黄瓜藤3份。
对比例3
一种鸡内金金钱草制品,和实施例2不同的是,包含以下重量份的原料组份:鸡内金1.5份、生姜4份、核桃仁6份、大金钱草5份、黑木耳4.5份、玉米须2 份、蒲公英2份、柴胡3份、龙胆草1.5份、纯香油2.5份,黄瓜藤3份、龙牙楤木2份。
对比例4
一种鸡内金金钱草制品,和实施例2不同的是,包含以下重量份的原料组份:鸡内金1.5份、生姜4份、核桃仁6份、大金钱草3份、黑木耳4.5份、玉米须1 份、蒲公英2份、柴胡3份、龙胆草1.5份、纯香油2.5份,黄瓜藤3份、龙牙楤木2份。
(1)对本发明制备的片剂进行动物急性毒性试验:
药物:本发明所用到的原料从普通中药店购买得到,其规格符合国家中药材标准。
试验对象:小白鼠,体重在50g左右,雌雄随机选择。
方法和结果:取小白鼠10只,饥饿24小时左右,按每只每天分两次灌喂本申请实施例2制备的中药组合物,每次10片,连续喂一周后,观察10天,小鼠活动正常,无毒性反应,无死亡,表明本发明的片剂无急性毒性,临床用药剂量安全。
(2)对本发明制备的片剂进行动物长期毒性试验:
试验动物:大白鼠,体重在120-130g,雌雄随机选择。
方法和结果:取大白鼠20只,分成2组,每组10只,其中第1组作为给药组,按每只每天2次灌喂,每次10片,第2组正常喂食作为对照组,连续90天,测体重,于最后一次给药后24小时断头处死,测血、尿常规、肝功能、肾功能,取心、肾等内脏,观察组织形态的变化,观察剂量的作用,观察饮食、活动的变化,实验证明给药组与对照组比较无显著变化,均无毒性反应,是一种安全的药物。
本申请制备的中药组合物进行了临床试验,临床诊断标准如下:
胆囊结石的诊断,首先是根据发病史,如常有右上腹部疼痛,并向右肩部放射、伴有发热等症状做出初步诊断,然后通过B超检查进行确诊,B超能够清晰地显示胆囊结石
本疗效评定标准是参照《中药新药临床研究指导原则》制定的,具体标准如下:
(1)痊愈:临床症状体征消失,肝功能正常,肝胆B超检查正常,B超复查结石排净;
(2)显效:临床症状体征消失,肝功能正常,肝胆B超检查正常,大便中排出结石,B超复查结石显著减少;
(3)有效:临床症状体征消失,总胆红素增高,肝胆B超检查提示胆囊内结石存在;
(4)无效:临床症状体征及辅助检查均未见好转。
治疗结果:为了验证临床疗效,本申请进行了临床试用,在自愿原则的前提下,随机选取其中210例病人,并随机分为七组,每组30人。
治疗方法:每组分别服用本实施例1-3以及对比例1-4制备的鸡内金金钱草制品片剂,每日两次,每次十片,早晚服用,两周为一个疗程,共三个疗程。
具体治疗结果参见表1。
服用结束三个疗程后进行统计,情况见下表1所示,说明本申请鸡内金金钱草制品具有明显的治疗胆结石的作用。
表1 疗效情况
通过表1中上述数据可知,在服用本发明的中药组合物之后,有效率维持在 90%-96.67%,其中治愈率维持在83.33%-93.33%。对比例1-对比例4由于配方中成分或者含量进行了调整,有效率仅维持在20%-43.33%,其中治愈率最高仅为23.33%.
以上数据进一步说明,本发明对于胆结石均有明显的治疗效果,按照疗程服用后,可以治疗胆结石,治愈率高,短期内无复发。另外本申请的原料种类少,为纯天然原料,安全可靠,无毒副作用,所选药材配伍相宜,符合中医药学和现代医药学理论,根据君臣佐使的配伍原则,对于胆结石的治疗达到意想不到的治疗效果,采用常规原料,便于取材,价格低廉,制备方法简单。
需要说明的是,以上各实施例仅用以说明本发明的技术方案,而非对其限制;尽管参照前述各实施例对本发明进行了详细的说明,本领域的普通技术人员应当理解:其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分或者全部技术特征进行等同替换;而这些修改或者替换,并不使相应技术方案的本质脱离本发明各实施例技术方案的范围。
Claims (8)
1.一种鸡内金金钱草制品,特征在于:包含以下重量份的原料组份:鸡内金1-3份、生姜3-5份、核桃仁4-8份、大金钱草2-4份、黑木耳3-6份、玉米须1.5-3份、蒲公英1-3份、柴胡1.5-4份、龙胆草1-2份、纯香油1-4份,黄瓜藤2-4份,龙牙楤木1-3份。
2.如权利要求1所述的一种鸡内金金钱草制品,其特征在于:包含以下重量份的原料组份:鸡内金1份、生姜3份、核桃仁4份、大金钱草2份、黑木耳3份、玉米须1.5份、蒲公英1份、柴胡1.5份、龙胆草1份、纯香油1份、黄瓜藤2份、龙牙楤木1份。
3.如权利要求1所述的一种鸡内金金钱草制品,其特征在于:包含以下重量份的原料组份:鸡内金1.5份、生姜4份、核桃仁6份、大金钱草3份、黑木耳4.5份、玉米须2份、蒲公英2份、柴胡3份、龙胆草1.5份、纯香油2.5份,黄瓜藤3份、龙牙楤木2份。
4.如权利要求1所述的一种鸡内金金钱草制品,其特征在于:包含以下重量份的原料组份:鸡内金3份、生姜5份、核桃仁8份、大金钱草4份、黑木耳6份、玉米须3份、蒲公英3份、柴胡4份、龙胆草2份、纯香油4份,黄瓜藤4份、龙牙楤木3份。
5.如权利要求1所述的一种鸡内金金钱草制品,其特征在于:所述鸡内金金钱草制品的剂型为散剂、粉剂、片剂、颗粒剂、汤剂、口服液、蜜膏体、蜜露、饮料或茶包制剂中的任意一种。
6.如权利要求1-5中任一项所述的鸡内金金钱草制品的制备方法,鸡内金金钱草制品为片剂,其特征在于:制备方法包括以下步骤:
(1).将鸡内金、生姜、核桃仁、大金钱草、黑木耳、玉米须、蒲公英、柴胡、龙胆草、黄瓜藤、龙牙楤木原料处理后按配比在粉碎车间粉碎后,称量;
(2).把步骤(1)中称量好的原料和纯香油在混合机中进行混合,设定混合时间、转速,混合好后放出原料;
(3).将混合好的原料采用压片机进行压片;
(4).压片后进行包装,包装完成后,产品化验室检测合格入库。
7.如权利要求6所述的一种鸡内金金钱草制品的制备方法,其特征在于:所述步骤(1)过筛前需要对鸡内金、生姜、核桃仁、大金钱草、黑木耳、玉米须、蒲公英、柴胡、龙胆草、黄瓜藤和龙牙楤木进行检验,检验合格后按配比在粉碎车间超微粉碎。
8.如权利要求6所述的一种鸡内金金钱草制品的制备方法,其特征在于:所述步骤(1)粉碎为超微粉碎,超微粉碎后超微粉粒径为10~60μm。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810638904.5A CN108902596A (zh) | 2018-06-20 | 2018-06-20 | 一种鸡内金金钱草制品及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810638904.5A CN108902596A (zh) | 2018-06-20 | 2018-06-20 | 一种鸡内金金钱草制品及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108902596A true CN108902596A (zh) | 2018-11-30 |
Family
ID=64420059
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810638904.5A Pending CN108902596A (zh) | 2018-06-20 | 2018-06-20 | 一种鸡内金金钱草制品及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108902596A (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102552822A (zh) * | 2012-02-21 | 2012-07-11 | 简福川 | 一种治疗胆石症的中药 |
CN105030834A (zh) * | 2015-09-14 | 2015-11-11 | 河南蓝天药业有限公司 | 一种治疗消化不良的药物及其制备工艺 |
CN106176904A (zh) * | 2016-08-27 | 2016-12-07 | 桂林七星粉业有限责任公司 | 一种具有降血糖效果的银杏保健片剂的加工工艺 |
CN106942728A (zh) * | 2017-04-20 | 2017-07-14 | 北京市永康年健康科技有限责任公司 | 一种苜蓿大麦制品及其制备方法和应用 |
-
2018
- 2018-06-20 CN CN201810638904.5A patent/CN108902596A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102552822A (zh) * | 2012-02-21 | 2012-07-11 | 简福川 | 一种治疗胆石症的中药 |
CN105030834A (zh) * | 2015-09-14 | 2015-11-11 | 河南蓝天药业有限公司 | 一种治疗消化不良的药物及其制备工艺 |
CN106176904A (zh) * | 2016-08-27 | 2016-12-07 | 桂林七星粉业有限责任公司 | 一种具有降血糖效果的银杏保健片剂的加工工艺 |
CN106942728A (zh) * | 2017-04-20 | 2017-07-14 | 北京市永康年健康科技有限责任公司 | 一种苜蓿大麦制品及其制备方法和应用 |
Non-Patent Citations (7)
Title |
---|
WANGXUE: "龙牙楤木的功效与作用", 《果蔬百科》 * |
徐平: "《实验动物管理与使用操作技术规程》", 31 August 2007, 上海科学技术出版社 * |
李不大: "《家庭常见病食疗必读》", 30 September 2005, 中国妇女出版社 * |
王惟恒: "《肝胆病千家妙方》", 31 August 2011, 人民军医出版社 * |
胡献国: "《三国演义与中医》", 31 May 2016, 湖北科学技术出版社 * |
苏冠群: "《胆囊炎胆结石诊疗与护理》", 31 October 2002, 内蒙古科学技术出版社 * |
黎宁: "《小简方治大病》", 30 September 2017, 广西科学技术出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100998843A (zh) | 一种治疗胆囊炎的药物组合物 | |
CN102441081B (zh) | 一种治疗痛风病的药物及其制备方法 | |
CN102631413B (zh) | 一种治疗痤疮的中药组合物 | |
US7005146B2 (en) | Complex prescription of chinese medicine for the treatment of extensive cancer | |
CN101926882A (zh) | 治疗癌症的药物组合物及其制备方法 | |
CN101011544A (zh) | 痛风速康颗粒(胶囊)及其制作工艺 | |
CN101143171B (zh) | 一种中药药物、其制备方法及其应用 | |
CN1857458A (zh) | 保健品、药物及制备方法 | |
CN104491220B (zh) | 一种治疗带状疱疹的中药组合物 | |
CN105943958A (zh) | 一种治疗痛风的桦褐孔菌复合固体颗粒及其制备方法 | |
CN103191331B (zh) | 用于治疗支气管哮喘缓解期的中药组合物 | |
CN104940718A (zh) | 一种治疗慢性胆囊炎的药物组合物及其制备方法 | |
CN101897733B (zh) | 一种治疗膀胱结石的药物及其制备方法 | |
CN103285162A (zh) | 用于补肾壮阳的中药组合物及其制备方法 | |
CN108902596A (zh) | 一种鸡内金金钱草制品及其制备方法 | |
CN100488526C (zh) | 仙硼疗氟口服制剂 | |
CN109078157A (zh) | 一种抗肿瘤药物及其制备方法 | |
CN108721567A (zh) | 一种软化肝胆结石的组合物及其制备方法 | |
CN103520644B (zh) | 用于治疗痰瘀型高脂血症的中药组合物及其制备方法 | |
CN108743766A (zh) | 一种金腰草五灵脂制品及其制备方法 | |
CN101461854B (zh) | 一种治疗结肠炎的中药制剂 | |
CN106390018A (zh) | 一种利胆中成药 | |
CN105748958A (zh) | 一种治疗肠功能紊乱的中药组合物 | |
CN104825955A (zh) | 一种用于治疗牛便秘的药物组合物及其制备方法 | |
CN108704109A (zh) | 一种治疗痤疮的中药组合物及其制作方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181130 |
|
RJ01 | Rejection of invention patent application after publication |